PAVmed Return on Equity (ROE) Growth & History (PAVM)
PAVmed's return on equity was 2.55% for fiscal 2025.
View full PAVmed company overviewPAVmed annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 2.55% | — |
| 2022 | 2022-12-31 | −342.34% | −183.92 pp |
| 2021 | 2021-12-31 | −158.42% | — |
| 2016 | 2016-12-31 | −3,589.54% | — |
PAVmed quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −14.44% | +14.45 pp |
| Q1 2026 | 2026-03-31 | −0.16% | −89.43 pp |
| Q4 2025 | 2025-12-31 | −3.80% | — |
| Q3 2025 | 2025-09-30 | −15.37% | — |
| Q2 2025 | 2025-06-30 | −28.89% | — |
| Q1 2025 | 2025-03-31 | 89.26% | — |
| Q3 2022 | 2022-09-30 | −168.96% | −137.53 pp |
| Q2 2022 | 2022-06-30 | −75.17% | −50.57 pp |
| Q1 2022 | 2022-03-31 | −31.36% | +4.79 pp |
| Q4 2021 | 2021-12-31 | −35.67% | — |
| Q3 2021 | 2021-09-30 | −31.42% | — |
| Q2 2021 | 2021-06-30 | −24.61% | — |
| Q1 2021 | 2021-03-31 | −36.15% | — |
| Q4 2018 | 2018-12-31 | −1,020.02% | — |
| Q3 2018 | 2018-09-30 | −63.35% | — |
| Q2 2018 | 2018-06-30 | −148.07% | — |
| Q4 2016 | 2016-12-31 | −414.85% | — |
| Q3 2016 | 2016-09-30 | −99.08% | — |
| Q2 2016 | 2016-06-30 | −97.88% | — |
| Q1 2016 | 2016-03-31 | −244.11% | — |
PAVmed return on equity trends
Between the periods ended 2016-12-31 and 2025-12-31, PAVmed's return on equity increased from −3,589.54% to 2.55%, a change of +3592.09 percentage points. The latest reported quarter, Q2 2026, shows −14.44%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PAVmed source filings ↗